Search results for "HIV"
Leflunomide gets boxed warning, ARBs under review
Recalls, warnings, approvals and other regulatory news.
https://immattersacp.org/archives/2010/09/fda.htm
1 Sep 2010
MKSAP Quiz: evaluation for chest discomfort and cough
A 45-year-old man is evaluated for right-sided chest discomfort and cough of 2 weeks' duration. His chest discomfort is described as a vague, painful sensation on the right. The cough occasionally produces a small amount of sputum; he reports no hemoptysis or shortness of breath. He has felt feverish with mild fatigue but has had no weight loss. He is a smoker with a 20-pack-year history. Following a physical exam and chest radiograph, what is the most appropriate management?
https://immattersacp.org/weekly/archives/2016/12/13/3.htm
13 Dec 2016
ACIP recommends seasonal flu vaccine for almost everyone
FDA reviewing safety of HIV drug combo Asthma drugs get risk management program
https://immattersacp.org/weekly/archives/2010/03/02/6.htm
2 Mar 2010
AIDS society updates antiretroviral recommendations for U.S. adults
MKSAP Quiz: generalized malaise and fatigue
https://immattersacp.org/weekly/archives/2010/07/27/2.htm
27 Jul 2010
Rehab with optional later knee surgery works for ACL tears
Routine, opt-out HIV tests detect modestly more cases
https://immattersacp.org/weekly/archives/2010/07/27/4.htm
27 Jul 2010
Major shift in thinking about cognitive impairment
Because neurocognitive decline can have a variety of etiologies, a new definition by the DSM-5 defined mild cognitive impairment as a syndrome, and then drilled down to its etiology.
https://immattersacp.org/archives/2019/07/major-shift-in-thinking-about-cognitive-impairment.htm
1 Jul 2019
Updated HIV guidelines issued
The U.S. Department of Health and Human Services issued updated guidelines April 8 on use of antiretroviral treatment in HIV-infected adults and adolescents.
https://immattersacp.org/weekly/archives/2015/04/21/5.htm
21 Apr 2015
Generic-based antiretroviral therapy may be cost-effective, mathematical simulation model indicates
Three-pill generic-based antiretroviral therapy is cost-effective and could offer cost savings compared with a branded single-pill regimen, a new study indicates.
https://immattersacp.org/weekly/archives/2013/01/15/2.htm
15 Jan 2013
Clarification to a previous issue
In last week's ACP InternistWeekly, the headline of the item on tuberculosis prevention in HIV patients should have read “WHO issues guidelines on TB prevention in people with HIV in resource-constrained settings.” The item has been updated.
https://immattersacp.org/weekly/archives/2010/12/14/15.htm
14 Dec 2010
Warning for tofacitinib; generic pregabalin approved
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2019/09/warning-for-tofacitinib-generic-pregabalin-approved.htm
1 Sep 2019